Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India Ratings and Research maintains Neutral Outlook for pharmaceuticals sector in FY26
Revenue growth projected at 9 % -10 % year-on-year; operating margins expected to remain stable
Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025
Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…
Vitafoods India 2025 ignites powerful knowledge exchange, elevating the future of nutraceuticals
Over 8,000 attendees and 150+ domestic and international exhibitors came together for the three-day event
Pharma funding surges 191% in January 2025 to $300 million
Private equity rounds drive majority of investments; Neuberg Diagnostics, Aragen, and Foxtale secure top deals
Dr. Reddy’s Secures Exclusive Rights to Commercialize HLX15 in U.S. & Europe
HLX15 is a recombinant anti-CD38 fully human monoclonal antibody injection, with intravenous as well as subcutaneous formulations
99 per cent of life sciences leaders see AI boosting revenue management in 2025: Report
Model N’s 2025 State of Revenue Report reveals shifts toward use of generative AI and automation to bolster pharmaceutical,…
Laboratory bench to life: Connecting biotechnology and sustainability impact
Praanjal Agarwal, Associate Director - Technical & Innovation at Sustain Labs Paris, highlights how the gap between innovation…
Anupriya Patel delivers keynote address at 15th IMWP
Reaffirms India’s commitment to global pharmaceutical standardisation and regulatory convergence
Indegene launches new entity in Spain
The company is strengthening its already existing employee base in Spain, with capabilities in medical affairs, data and…
Decoding the M&A landscape
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing…